Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 105

Similar articles for PubMed (Select 21438686)

1.

Reward, addiction, withdrawal to nicotine.

De Biasi M, Dani JA.

Annu Rev Neurosci. 2011;34:105-30. doi: 10.1146/annurev-neuro-061010-113734. Review.

2.

Synaptic plasticity and nicotine addiction.

Dani JA, Ji D, Zhou FM.

Neuron. 2001 Aug 16;31(3):349-52. Review.

3.

Neurophysiology of Nicotine Addiction.

Dani JA, Jenson D, Broussard JI, De Biasi M.

J Addict Res Ther. 2011 Apr 20;S1(1). pii: 001.

4.

The α3β4* nicotinic acetylcholine receptor subtype mediates nicotine reward and physical nicotine withdrawal signs independently of the α5 subunit in the mouse.

Jackson KJ, Sanjakdar SS, Muldoon PP, McIntosh JM, Damaj MI.

Neuropharmacology. 2013 Jul;70:228-35. doi: 10.1016/j.neuropharm.2013.01.017. Epub 2013 Feb 13.

5.

The role of alpha6-containing nicotinic acetylcholine receptors in nicotine reward and withdrawal.

Jackson KJ, McIntosh JM, Brunzell DH, Sanjakdar SS, Damaj MI.

J Pharmacol Exp Ther. 2009 Nov;331(2):547-54. doi: 10.1124/jpet.109.155457. Epub 2009 Jul 30.

6.

α4β2 nicotinic acetylcholine receptors on dopaminergic neurons mediate nicotine reward and anxiety relief.

McGranahan TM, Patzlaff NE, Grady SR, Heinemann SF, Booker TK.

J Neurosci. 2011 Jul 27;31(30):10891-902. doi: 10.1523/JNEUROSCI.0937-11.2011.

7.

Involvement of neuronal β2 subunit-containing nicotinic acetylcholine receptors in nicotine reward and withdrawal: implications for pharmacotherapies.

Simmons SJ, Gould TJ.

J Clin Pharm Ther. 2014 Oct;39(5):457-67. doi: 10.1111/jcpt.12171. Epub 2014 May 14. Review.

PMID:
24828779
8.

Mesolimbic dopamine and habenulo-interpeduncular pathways in nicotine withdrawal.

Dani JA, De Biasi M.

Cold Spring Harb Perspect Med. 2013 Jun 1;3(6). pii: a012138. doi: 10.1101/cshperspect.a012138.

9.

Mechanistic insights into nicotine withdrawal.

Paolini M, De Biasi M.

Biochem Pharmacol. 2011 Oct 15;82(8):996-1007. doi: 10.1016/j.bcp.2011.07.075. Epub 2011 Jul 20. Review.

10.

Mysterious alpha6-containing nAChRs: function, pharmacology, and pathophysiology.

Yang KC, Jin GZ, Wu J.

Acta Pharmacol Sin. 2009 Jun;30(6):740-51. doi: 10.1038/aps.2009.63. Review.

11.

Differential desensitization and distribution of nicotinic acetylcholine receptor subtypes in midbrain dopamine areas.

Wooltorton JR, Pidoplichko VI, Broide RS, Dani JA.

J Neurosci. 2003 Apr 15;23(8):3176-85.

12.

Subtypes of nicotinic acetylcholine receptors in nicotine reward, dependence, and withdrawal: evidence from genetically modified mice.

Fowler CD, Arends MA, Kenny PJ.

Behav Pharmacol. 2008 Sep;19(5-6):461-84. doi: 10.1097/FBP.0b013e32830c360e. Review.

13.

Role of α7- and β4-containing nicotinic acetylcholine receptors in the affective and somatic aspects of nicotine withdrawal: studies in knockout mice.

Stoker AK, Olivier B, Markou A.

Behav Genet. 2012 May;42(3):423-36. doi: 10.1007/s10519-011-9511-0. Epub 2011 Oct 19.

14.
15.

Cortico-thalamic connectivity is vulnerable to nicotine exposure during early postnatal development through α4/β2/α5 nicotinic acetylcholine receptors.

Heath CJ, King SL, Gotti C, Marks MJ, Picciotto MR.

Neuropsychopharmacology. 2010 Nov;35(12):2324-38. doi: 10.1038/npp.2010.130. Epub 2010 Aug 25.

16.

Age dependent nicotinic influences over dopamine neuron synaptic plasticity.

Placzek AN, Zhang TA, Dani JA.

Biochem Pharmacol. 2009 Oct 1;78(7):686-92. doi: 10.1016/j.bcp.2009.05.014. Epub 2009 May 21. Review.

17.

Effects of prazosin, clonidine, and propranolol on the elevations in brain reward thresholds and somatic signs associated with nicotine withdrawal in rats.

Bruijnzeel AW, Bishnoi M, van Tuijl IA, Keijzers KF, Yavarovich KR, Pasek TM, Ford J, Alexander JC, Yamada H.

Psychopharmacology (Berl). 2010 Dec;212(4):485-99. doi: 10.1007/s00213-010-1970-0. Epub 2010 Aug 10.

18.

Assembly of human neuronal nicotinic receptor alpha5 subunits with alpha3, beta2, and beta4 subunits.

Wang F, Gerzanich V, Wells GB, Anand R, Peng X, Keyser K, Lindstrom J.

J Biol Chem. 1996 Jul 26;271(30):17656-65.

19.

Mechanisms involved in systemic nicotine-induced glutamatergic synaptic plasticity on dopamine neurons in the ventral tegmental area.

Gao M, Jin Y, Yang K, Zhang D, Lukas RJ, Wu J.

J Neurosci. 2010 Oct 13;30(41):13814-25. doi: 10.1523/JNEUROSCI.1943-10.2010.

20.

Synaptic plasticity within midbrain dopamine centers contributes to nicotine addiction.

Placzek AN, Dani JA.

Nebr Symp Motiv. 2009;55:5-15. Review. No abstract available.

PMID:
19013936
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk